Needs Assessment After Cancer in Patients Treated for Breast Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03902964

Acronym

EACE

Enrollment

139

Registered

2019-04-04

Start date

2018-12-01

Completion date

2019-02-01

Last updated

2019-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasm Female, Fear Cancer, Quality of Life

Brief summary

observational monocentric study

Detailed description

observational monocentric study Primary objective : Describe post-cancer supportive care needs, assessed by questionnaire in patients treated for breast cancer after completion of treatment and 2 years later. Secondary objective : * Correlation between needs after cancer and the fear of recidivism assessed by the scale of the inventory of fear. * Compare the need for supportive care between the end of treatment and 2 years after. * Assess needs after cancer according to the stage of the disease * Evaluate the needs after cancer according to the treatments received: surgery-radiotherapy versus surgery-chemotherapy-radiotherapy. * Assess needs after cancer according to age and socio-professional category. Schedule : The selected patients then received a letter including an information and non-objection note, the post-cancer needs questionnaire, the Fear Inventory severity subscale questionnaire, and the QLQ-C30 questionnaire. A delay of 1 month was chosen to return the questionnaire with a phone call after 15 days for an analysis of responses in February 2019.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

Women who have been treated for breast cancer and whose treatment ended in 2017 (cohort A) and in 2015 (cohort B), aged between 18 and 80 years, and who declared their non-opposition free and enlightened.

Exclusion criteria

Patients who have been treated for recurrence or 2nd cancer, metastases from the outset, male, refusal to participate.

Design outcomes

Primary

Measure	Time frame	Description
Post-cancer needs analysis	2 years	Post-cancer needs analysis based on the post-cancer needs assessment questionnaire for patients in both cohorts

Countries

France

Outcome results